Related Experiment Video
Updated: Jun 21, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm
Panagiotis G Asteris1, Eleni Gavriilaki2, Polydoros N Kampaktsis3
1Computational Mechanics Laboratory, School of Pedagogical and Technological Education, Athens, Greece.
This study identifies key cardiovascular disease (CVD) predictors using an AI algorithm. Platelet-derived Microvesicles (PMV), hypertension, and BMI are crucial for accurate CVD risk prediction.
Area of Science:
- Cardiology
- Artificial Intelligence
- Biomedical Data Science
Background:
- Cardiovascular disease (CVD) poses a significant global health challenge.
- Accurate prediction of CVD risk is essential for early intervention and management.
- Identifying key predictive parameters is crucial for developing effective diagnostic tools.
Purpose of the Study:
- To determine the most crucial parameters associated with cardiovascular disease (CVD).
- To employ a novel data ensemble refinement procedure to uncover the optimal pattern of these parameters for high prediction accuracy.
- To enhance early diagnosis and optimize resource utilization in CVD risk assessment.
Main Methods:
- Analysis of data from 369 patients (281 with CVD or at risk, 88 healthy).
- Utilized an artificial intelligence-based algorithm, including DERGA and Extra Trees, for pattern identification.
- Evaluated the predictive power of various parameters, including Platelet-derived Microvesicles (PMV), hypertension, age, smoking, dyslipidemia, and Body Mass Index (BMI).
Main Results:
- A six-parameter combination, including PMV, hypertension, age, smoking, dyslipidemia, and BMI, effectively discerns CVD likelihood.
- The highest prediction accuracy achieved was 98.64%.
- Platelet-derived Microvesicles (PMV) alone yielded 91.32% accuracy, while a ten-parameter model achieved 97.83% accuracy.
Conclusions:
- The DERGA algorithm effectively identifies critical parameters for CVD risk assessment.
- This approach accelerates CVD risk assessment, enabling earlier diagnosis and reducing the need for extensive lab tests.
- The findings enhance understanding of CVD susceptibility and optimize resource allocation in healthcare.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Statistical Methods for Analyzing Epidemiological Data
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Statistical Software for Data Analysis and Clinical Trials
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...